Category: Regulatory Issues

Vaping Irony

Check this out. What you will see is the work of a medical writer asking a good question. Why, a full 50 years after cigarette advertising was banned on TV, are we still seeing advertisements for Juul being televised?   I get it. It takes regulatory bodies a while...

Continue reading

When Is Cheaper Not???

Check this out. Yup. EpiPen pricing again. We haven’t talked about this inflammatory issue in quite some time. But here we go again. Strange back story here. The FDA proudly announced that in approving a TEVA generic for EpiPen, it was offering the public a “lower-cost...

Continue reading

And Here We Go Again!!!

It seems like every year or so, I write another post on upcoming FDA studies that seem a little silly.  Sometimes more than a little silly, actually. This year is no exception. Check this one out! What you will see is an announcement of the usual studies aimed...

Continue reading

Disclosures!?!?

Yup! Here comes another FDA study. This one is going to try to determine the extent to which medical professionals are misled by advertisements for oncology drugs, and the impact that various forms of “disclosures” have on doctors’ understanding of the drugs. The...

Continue reading

How Appropriate…

that Dr. Matthew Hahn, the physician pictured here, is shown standing on a bridge. Why? Hahn is a firm believer that the U.S. healthcare “system” is ruining healthcare as we cross a bridge into the future.  He believes that regulations are strangling practitioners....

Continue reading

HIPAA And Civil Liability

Please pardon the lawyer speak in the title here, but that is sort of what this post is about. Check out this piece. It is about the two lap top computers, stolen from Horizon Blue Cross Blue Shield, that contained unencrypted information about 840,000 plan members....

Continue reading

First Amendment!!!

Check this out. What you will see is the report on a Federal court ruling that maintains that as long as the information being disseminated by a drug company about a product is true, it doesn’t matter whether or not the information is about an indication that is...

Continue reading